U.S. flag

An official website of the United States government

NM_014319.5(LEMD3):c.1808_1812del (p.Thr603fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 19, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001869628.3

Allele description [Variation Report for NM_014319.5(LEMD3):c.1808_1812del (p.Thr603fs)]

NM_014319.5(LEMD3):c.1808_1812del (p.Thr603fs)

Gene:
LEMD3:LEM domain containing 3 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q14.3
Genomic location:
Preferred name:
NM_014319.5(LEMD3):c.1808_1812del (p.Thr603fs)
HGVS:
  • NC_000012.12:g.65238701_65238705del
  • NG_016210.2:g.74131_74135del
  • NM_001167614.2:c.1805_1809del
  • NM_014319.5:c.1808_1812delMANE SELECT
  • NP_001161086.1:p.Thr602fs
  • NP_055134.2:p.Thr603fs
  • NC_000012.11:g.65632481_65632485del
Protein change:
T602fs
Links:
dbSNP: rs2136353868
NCBI 1000 Genomes Browser:
rs2136353868
Molecular consequence:
  • NM_001167614.2:c.1805_1809del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_014319.5:c.1808_1812del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002198449Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 19, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis.

Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert JM, Vandesompele J, Speleman F, Verschueren K, Coucke PJ, Mortier GR.

Nat Genet. 2004 Nov;36(11):1213-8. Epub 2004 Oct 17.

PubMed [citation]
PMID:
15489854

Novel and recurrent germline LEMD3 mutations causing Buschke-Ollendorff syndrome and osteopoikilosis but not isolated melorheostosis.

Zhang Y, Castori M, Ferranti G, Paradisi M, Wordsworth BP.

Clin Genet. 2009 Jun;75(6):556-61. doi: 10.1111/j.1399-0004.2009.01177.x. Epub 2009 May 5. Erratum in: Clin Genet. 2011 Apr;79(4):401.

PubMed [citation]
PMID:
19438932
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV002198449.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with LEMD3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr603Asnfs*3) in the LEMD3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LEMD3 are known to be pathogenic (PMID: 15489854, 19438932).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024